EyePoint Inc (EYPT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$15.28

Buy

$16.60

arrow-down$-0.11 (-0.68%)

Prices updated at 12 Dec 2025, 21:10 EST

Prices minimum 15 mins delay

Prices in USD

EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Dr. Goran A. Ando, M.D.

CEO

Dr. Jay S. Duker, M.D.

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

144

Head office

480 Pleasant Street

Watertown

United States

02472

+1 833 393-7646

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Reginald Sanders, M.D. Director	-
Mr. Fred Hassan Director	0.02m
Ms. Nancy S. Lurker Executive Vice Chairman of the Board	0.04m
Ms. Wendy F. DiCicco Independent Director	0.08m
Mr. George O. Elston Executive Vice President, Chief Financial Officer and Principal Accounting Officer	0.51m
Dr. John B. Landis, PhD Director	0.46m
Ms. Karen Zaderej Independent Director	0.06m
Dr. Jay S. Duker, M.D. Director, President and Chief Executive Officer	0.67m
Dr. Goran A. Ando, M.D. Chairman of the Board	0.10m
Mr. Stuart M. Duty Independent Director	0.06m
Dr. Ramiro Ribeiro, M.D.,PhD Chief Medical Officer	0.40m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Cormorant Asset Management, LP	8,325,000
Cormorant Asset Management, LLC	8,325,000
Suvretta Capital Management, LLC	6,192,715
Franklin Advisers, Inc.	5,989,176
Adage Capital Partners Gp LLC	5,559,782

Director dealings

Date chevron-l-regular chevron-r-regular	Action
03 Sep 2024	-
21 Aug 2024	-
20 Aug 2024	-
19 Aug 2024	-
16 Aug 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
26 Jul 2024	-
12 Jul 2024	-
12 Jul 2024	-
12 Jul 2024	-
12 Jul 2024	-
12 Jul 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.